HomeNewsRespiratory

  • Genkyotex announces Ph 2 trial for GKT831 in Patients with IPF

    • August 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE advises restricted use of antibiotics for COPD

    • July 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Spiriva Respimat gets UK license for young asthma patients

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Kalydeco (ivacaftor) Data Demonstrates Early and Long-Term Disease-Modifying Potential of Treating the Underlying Cause of Cystic Fibrosis

    • June 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Glenmark Pharma submits Company’s First New Drug Application for Ryaltris™ for Patients with Seasonal Allergic Rhinitis

    • May 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Bellerophon to Present Positive Results from Phase 2 Study of INOpulse® for Treatment of Pulmonary Hypertension Associated with COPD at ATS Conference

    • May 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • AstraZeneca’s Fasenra Fails in Phase III COPD Trial

    • May 11, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verona Pharma to Present Clinical Trial Data of RPL554 at ATS (American Thoracic Society 2018) Conference

    • May 9, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Verona Pharma to Mark its Presence at BioEquity Europe 2018

    • May 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Vertex Initiates Phase 3 Studies of VX-445, Tezacaftor and Ivacaftor as a Triple Combination Regimen for People with Cystic Fibrosis

    • April 30, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more